<DOC>
	<DOCNO>NCT01065792</DOCNO>
	<brief_summary>This survey conduct prepare application material re-examination Pharmaceutical Affairs Laws Enforcement Regulation , aim reconfirm clinical usefulness STOCRIN collect safety efficacy information accord Re-examination Regulation New Drugs . Post-marketing survey consider applicable clinical trial thus result survey post conclusion . The result submit public health official require applicable national international law .</brief_summary>
	<brief_title>Stocrin Re-examination Study ( 0831-028 )</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<criteria>HIV1 Infected Patient Patient Who Is Treated With Stocrin 600 Mg Tablet Within Local Label During The Enrollment Period ( A Patient Who Changes The Therapy From Stocrin 200 Mg Capsule To Stocrin 600 Mg Tablet Can Be Eligible . ) Patient Who Has A Contraindication To Stocrin According To The Local Label</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>HIV Infection</keyword>
</DOC>